摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

中文名称
——
中文别名
——
英文名称
(3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
英文别名
——
(3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione化学式
CAS
——
化学式
C27H41NO6S
mdl
——
分子量
507.7
InChiKey
QXRSDHAAWVKZLJ-ITERPUOLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    35
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.74
  • 拓扑面积:
    138
  • 氢给体数:
    2
  • 氢受体数:
    8

文献信息

  • [EN] EPOTHILONE ANALOGS, METHODS OF SYNTHESIS, METHODS OF TREATMENT, AND DRUG CONJUGATES THEREOF<br/>[FR] ANALOGUES D'ÉPOTHILONE, PROCÉDÉS DE SYNTHÈSE, PROCÉDÉS DE TRAITEMENT, ET CONJUGUÉS MÉDICAMENTEUX DE CEUX-CI
    申请人:UNIV RICE WILLIAM M
    公开号:WO2017066606A1
    公开(公告)日:2017-04-20
    In one aspect, the present disclosure provides epothilone analogs of the formula (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides methods of preparing the compounds disclosed herein. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the compounds disclosed herein. Additionally, drug conjugates with cell targeting moieties of the compounds are also provided.
    在一个方面,本公开提供了公式(I)中变量如本文所定义的紫杉醇类似物。在另一个方面,本公开还提供了制备本文披露的化合物的方法。在另一个方面,本公开还提供了药物组合物和使用本文披露的化合物的方法。此外,还提供了具有细胞靶向基团的药物共轭物。
  • Synthesis of Epothilones, Intermediates Thereto, Analogues and Uses Thereof
    申请人:Danishefsky Samuel J.
    公开号:US20090149516A1
    公开(公告)日:2009-06-11
    The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I).
    本发明提供了公式(I)的化合物,如在此处一般描述的类别和子类中描述的那样。本发明还提供了包括公式(I)化合物的制药组合物,并提供了使用公式(I)化合物治疗癌症的方法。
  • Synthesis of epothilones, intermediates thereto and analogues thereof
    申请人:Danishefsky J. Samuel
    公开号:US20070032534A1
    公开(公告)日:2007-02-08
    The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I).
  • SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO AND ANALOGUES THEREOF
    申请人:Sloan-Kettering Institute for Cancer Research
    公开号:US20140213618A1
    公开(公告)日:2014-07-31
    The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I).
  • US7244594B2
    申请人:——
    公开号:US7244594B2
    公开(公告)日:2007-07-17
查看更多